Evaluation and Interpretation

A number outside the printed interval is not automatically important, and a number inside it is not automatically safe. The technologist weighs each result against the patient's own history, the size of change that analytical and biological variation can produce on their own, and the clinical consequence of the finding. Small drifts in a stable outpatient usually mean nothing; a modest change in a critical analyte may mean a great deal. The practical skill is triage — sorting the panel into what can be released routinely, what needs repeating, and what needs a telephone call now.

Automated chemistry results carry assumptions with them — about matrix, about specimen quality, about the measuring principle. The technologist reviews instrument flags, haemolysis-icterus-lipaemia indices, reaction curves and linearity limits before releasing anything, and asks whether the method was ever validated for the specimen in hand. Serum and plasma are the default; cerebrospinal, pleural, peritoneal, synovial and dialysate specimens need documented in-house verification and a matrix comment on the report. Where two instruments disagree on the same draw, the task is to work out which measuring principle is telling the truth.

Digital imaging now carries urine sediment, gel reactions and referred microscopy between sites, and the technologist may have to interpret a field they never focused themselves. That changes the review: judge whether the capture is adequate — in focus, correctly magnified, properly illuminated, showing enough fields — before judging what is in it. Low-refractile elements such as hyaline casts are easily lost in a bright capture, and a screen colour cast can mislead. When the image cannot support a confident call, the correct action is to request the specimen or a fresh capture, not to guess.

A satellite collection centre uploads a 400× digital image of an unstained urine sediment because its automated system could not classify the structures. The urine pH is 8.0. The field shows colourless, three-dimensional prisms with obliquely bevelled ends. What identification fits the image?

ACholesterol platesBCystine crystalsCTriple phosphateDCalcium oxalate

Some results are not merely abnormal — they are incompatible with a living patient or with each other. The technologist checks each panel for internal coherence: do the electrolytes give a sensible anion gap, does the calcium fit the albumin, does the pattern match a known pre-analytical artefact? Classic culprits are contamination from an infusion line, carry-over from an anticoagulated tube, haemolysis, and specimen misidentification. A result that reproduces perfectly on repeat testing is not thereby correct; reproducibility only proves the tube is consistent, not that the tube belongs to the patient named on it.

Blood gas specimens degrade faster than any other chemistry sample, so validity is assessed before interpretation. The technologist checks the anticoagulant and fill volume, looks for clots and air bubbles, confirms the collection-to-analysis interval and transport temperature, and verifies that the sample was properly mixed. Air contamination pulls the pO2 toward atmospheric values and drives carbon dioxide off; delay at room temperature lets leukocytes consume oxygen and generate acid. The results are then checked for internal coherence — pH against pCO2 and bicarbonate, and measured oxygen saturation against pO2 on the dissociation curve.

Commercial kits — lateral-flow devices, latex agglutination cards, tube tests and point-of-care cartridges — carry their acceptance rules in the package insert, and those rules are part of the result. The technologist confirms that the lot is in date and stored correctly, that the internal procedural control developed, and that the reading was made inside the stated time window and under the stated lighting. Readings taken late are not valid, because evaporation and non-specific binding generate lines and clumps that were never there at the correct read time. Qualitative kit results are also confirmed by a quantitative method where the clinical stakes warrant it.